CClinicalTrials.gg
RecruitingNCT06499623MALNUTRITIONUpdated Oct 3, 2024

Early Detection of Malnutrition in Oncology Patients and Elderly Patients

An observational study in Malnutrition, sponsored by Institute of Health Information and Statistics of the Czech Republic. Recruiting at 9 sites in Czechia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-03.

Sponsored by Institute of Health Information and Statistics of the Czech Republic · Observational

From the registry’s dates

  • Primary completion was expected by Nov 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Aug 2024; still recruiting 2 years 1 month later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,000
Ages
18 Years and older
Sex
All
01

Study summary

The project is a national, prospective, multicenter, non-interventional pilot project of malnutrition screening in the Czech Republic.

The main goal of the project is to methodically prepare, implement and evaluate a pilot project that will verify the suitability of the proposed procedure for the early detection of malnutrition in oncology patients and hospitalised patients patients 65 years of age and older, as this has a significant effect on the quality of life and the effectiveness of the services provided oncological treatment.

Read the detailed description

The main goal of the project is the early detection of malnutrition in oncology patients and hospitalised patients 65 years of age and older, as this has a significant effect on the quality of life and the effectiveness of the services provided oncological treatment.

Another goal of the project will be the creation of a unified diagnostic proposal process and methodological material for determining malnutrition. This process will then be designed as the standard of nursing practice for patients with an oncological diagnosis and for persons older than 65 years such that, so that an adequate nutritional intervention is started in time, which will lead to a higher tolerance of demanding treatment and thus to increase the quality of life.

The project will include testing the procedure on a sample of approx. 1,500 oncological and 500 geriatric patients.

The project is supported by the European Social Fund (Operational Program Employment plus) and the state budget of the Czech Republic and is registered by the Ministry of Labour and Social Affairs of the Czech Republic under ID: CZ.03.02.02/00/22_005/0000282.

02

Conditions studied

  • Malnutrition

Browse trials for

Keywords

  • malnutrition
  • oncology
  • gerontology
03

In context

Malnutrition

1,587 studies on the registry are indexed under Malnutrition; 237 are open to participants now.

This study's planned enrollment of 2,000 is above the median of 203 across 388 observational studies indexed under Malnutrition.

Browse Malnutrition studies →

Lead sponsor

Institute of Health Information and Statistics of the Czech Republic is the lead sponsor of 14 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Individuals with oncological diagnosis with age 18+ or patients with hospitalization at least 14 days and age 65+.

Inclusion criteria

Cohort Oncological patients:

  • 18+
  • an oncological diagnosis
  • a survival prognosis of at least 3 months

Cohort Patients older than 65 years:

  • 65+
  • hospitalization at least 14 days or longer

Exclusion criteria

Exclusion Criteria (both cohorts):

  • not agreeing to participate in the project
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Oncological patients

    The inclusion criteria for the cohort of oncological patients are age 18+, an oncological diagnosis and a survival prognosis of at least 3 months.

    Diagnostic Test: Blood test · Diagnostic Test: Bioelectrical Impedance Analysis · Other: Nutritional Risk Assessment Questionnaire

  • Patients older than 65 years

    The inclusion criteria for this cohort are age 65 and older and hospitalization at least 14 days or longer.

    Diagnostic Test: Blood test · Diagnostic Test: Bioelectrical Impedance Analysis · Other: Nutritional Risk Assessment Questionnaire

Interventions

  • Diagnostic testBlood test

    Albumin, C-Reactive Protein, Cholesterol, Urea, Creatinine, Vitamin D

  • Diagnostic testBioelectrical Impedance Analysis

    Total Impedance, Segmental Muscle Analysis, Segmental Fat Analysis, Absolute Muscle Mass Value, Muscle Mass Index, Total Body Fat Percentage, Total Body Water, Phase Angle Measurement

  • OtherNutritional Risk Assessment Questionnaire

    Fill in the Questionnaire of the Working Group on Nutritional Care in Oncology and get nutrition risk score. The objective data includes weight loss in 6 months, current BMI and food tolerance, and oncological diagnosis including ongoing anti-cancer treatment.

06

What researchers measure

Primary outcomes

  1. Number of people with malnutrition according to the PSNPO questionnaire

    Time frame: Until 31. 3. 2026

Secondary outcomes

  1. Proportion of people with initiated nutritional intervention

    Time frame: Until 31. 3. 2026

07

Study locations

9 of 9 sites recruiting
  • Brno University Hospital
    Brno, 60200, Czechia
    Enrolling by invitation
  • Masaryk Memorial Cancer Institute
    Brno, 60200, Czechia
    • Andrea Jurečková, MD · Contact · jureckova@mou.cz
    • Věra Andrášková, MSc · Principal investigator
    • Andrea Jurečková, MD · Principal investigator
    Recruiting
  • Hospital AGEL Nový Jičín a.s.
    Nový Jičín, Czechia
    Recruiting
  • University Hospital Olomouc
    Olomouc, Czechia
    Enrolling by invitation
  • University Hospital Pilsen
    Pilsen, Czechia
    Enrolling by invitation
  • Bulovka Hospital
    Prague, Czechia
    Recruiting
  • General University Hospital, Prague
    Prague, Czechia
    Enrolling by invitation
  • Military University Hospital, Prague
    Prague, Czechia
    • Denisa Janíčková Ždárská, Assoc. Prof. · Contact · Denisa.janickova.zdarska@email.cz · 973 208 334
    • Denisa Janíčková Ždárská, Assoc. Prof. · Principal investigator
    Recruiting
  • University Hospital, Motol
    Prague, Czechia
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06499623
Lead sponsor
Institute of Health Information and Statistics of the Czech Republic
Collaborators
Brno University Hospital, Bulovka Hospital, Masaryk Memorial Cancer Institute, University Hospital, Motol, Hospital AGEL Nový Jičín a.s., Military University Hospital, Prague, General University Hospital, Prague, University Hospital Olomouc, University Hospital Pilsen
Responsible party
Sponsor
First posted
Jul 12, 2024
Start date
Aug 29, 2024
Primary completion
Nov 30, 2025 (estimated)
Completion
Mar 31, 2026 (estimated)
Last update
Oct 3, 2024

Study contacts

Nikola Stourac
Contact
nikola.stourac@uzis.cz
+420 739 012 354
Lucie Mandelova, PhD
Contact
lucie.mandelova@uzis.cz
+420 770 190 828
Petra Beran Holeckova, MD
study director · Charles University First Faculty of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion